Day 2 - Afternoon

Group 5A: Metastatic Breast Cancer; ER+; Treatment Resistance; Immunology; Novel Drug Sold Out

Group 5I: Lobular Breast Cancer; Liquid Biopsy; Antibody-Drug Conjugates Sold Out

Group 5B: Metastatic Breast Cancer; Genomic Testing; TNBC; Machine Learning

Group 5C: Survivorship; Cardiovascular Risks; Diabetes; Food Insecurity

Group 5D: Triple Negative Breast Cancer; Immunotherapy; Tumor Immune Microenvironment; Treatment Outcomes Sold Out

Group 5E: Metastatic Breast Cancer; Brain Metastases; Her2-low; Genomics Sold Out

Group 5F: Breast Cancer Susceptibility; Epigenetics; Patient-Led Education; Health Literacy

Group 5G: Metastatic Breast Cancer; ER+; Liquid Biopsy; Biomarkers Last Few Tickets

Group 5H: Metastatic Breast Cancer; Cancer Genomics; Clinical Outcomes; Microenvironment Sold Out